LIPO-Liposome Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LIPO-Liposome

LIPO 0.350

-4.4%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Grandk who wrote (850)	9/21/1999 10:09:00 AM
From: 613	Read Replies (1) of 900

They are profitable and should still earn .20-.25 per share this year. But EVACET was going to be the killer drug. As a 1 drug company, I hope they sell out now, unless they have some other trick up their sleeve. IMO, buying more is a safe LONG term bet.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next